Mob/WS: 86 15132971817

       E-mail: admin@mokemei.com

PNC-27

PNC-27

01.Sommarlutide is a long-acting formulation based on the basic structure of Liraglutide, which is more effective in the treatment of type 2 diabetes..

02.Semeglutide is a GLP-1(7-37) chain with 8-position Aib replacing Ala, 34-position Arg replacing Lys, and 26-position Lys attached to the stearic acid fatty chain.

03.Compared with Liraglutide, Semeglutide's fat Chemicalbook chain is longer and its hydrophobicity is increased, but Semeglutide is modified with short chain PEG and its hydrophilicity is greatly enhanced.

04.After PEG modification, it can not only bind to albumin closely, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong biological half-life, and achieve a long cycle effect.
Price: $0.00

Grade Standard

Medicine Grade

Type

Chemical Reagent

State

Solid

Volatile

Not Volatile

Products Name

PNC-27

Shelf Life

1 Years

Storage Condition

Normal

Colour

Powder

Sample

Available

Standaed

GMP

Assay

>99%

CAS

9104 63-68-2

Melting Point

89°c

Specific Rotation

25D -256°

Delivery

5-8 Days

Boiling Point

574.5±50.0 °c(Predicted)

Mf

C187h291n45o59

Merck

14, 8090

Kpa

13.63±0.46

Transport Package

Carton

Specification

10g/BOTTLE

Trademark

Jinan Andechem

Origin

Jinan

HS Code

29309090

Production Capacity

5000kg/Month
















Description:

01.Sommarlutide is a long-acting formulation based on the basic structure of Liraglutide, which is more effective in the treatment of type 2 diabetes..

02.Semeglutide is a GLP-1(7-37) chain with 8-position Aib replacing Ala, 34-position Arg replacing Lys, and 26-position Lys attached to the stearic acid fatty chain.

03.Compared with Liraglutide, Semeglutide's fat Chemicalbook chain is longer and its hydrophobicity is increased, but Semeglutide is modified with short chain PEG and its hydrophilicity is greatly enhanced.

04.After PEG modification, it can not only bind to albumin closely, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong biological half-life, and achieve a long cycle effect.

USD:

Se maglutide (Rybelsus, O zempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analogue and agonist of the GLP-1 receptor. It has potential therapeutic efficacy for type 2 diabetes mellitus (T2DM).

Name
Phone
Email
Corporate name
Address
Leaving Message*
 
Verification code
Submit
Previous: PNC-27
Next: Pinealon